bf/NASDAQ:ATHA_icon.png

NASDAQ:ATHA

Athira Pharma

  • Stock

USD

Last Close

4.01

06/11 21:17

Market Cap

126.10M

Beta: 2.82

Volume Today

51.22K

Avg: 246.55K

PE Ratio

−1.03

PFCF: −1.30

OverviewFinancialsAPI

    Description

    Athira Pharma, Inc., a late clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. The company's lead product candidate is ATH-1017, a blood brain barrier-penetrating, small molecule HGF/MET positive modulator that is in LIFT-AD Phase 3 and ACT-AD Phase 2 clinical trials for the treatment of Alzheime...Show More

    Excel Tearsheet

    Earnings

    Earnings per Share (Estimate*)

    -1.2-1-0.8-0.6-0.4-0.22019-09-302021-05-132022-11-102024-05-092025-02-27

    Revenue (Estimate*)

    0.000.000.010.010.012019-09-302021-05-132022-11-102024-05-092025-02-27

    *Estimate based on analyst consensus